Tysabri 300mg Injection

Tysabri 300mg Injection contains Natalizumab, an immunomodulatory medication used to treat some autoimmune diseases by blocking particular immune system pathways.

Brand Name: Tysabri

Composition: Natalizumab

Mechanism of Action:

An anti-α4 integrin monoclonal antibody called natalizumab stops immune cells from migrating into the central nervous system (CNS) by preventing white blood cells' α4 integrins from interacting with endothelial cells' vascular cell adhesion molecule-1 (VCAM-1).

Uses:

• Multiple Sclerosis
• Crohn’s Disease

Dosage and Administration:

Administered via infusion into the vein. Every four weeks, 300 mg is the standard dosage. The infusion is usually administered over a period of one hour.

Side Effects:

• Headache
• Fever
• Dizziness
• Fatigue
• Joint pain

Safety Advise:

Lungs  

The safety of Tysabri for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Tysabri for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Tysabri for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Tysabri should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Tysabri while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.

How to use this Medication?

Injection preparations for natalizumab are available as a concentrated liquid solution that a physician or nurse can dilute and administer gradually into a vein. In a licensed infusion facility, it is typically administered once every four weeks. You will receive your full dose of natalizumab injectable product in approximately one hour.

Serious adverse responses to natalizumab are possible at any point throughout treatment, however most usually occur two hours after infusion. Particularly during the first 12 infusions, remain at the infusion facility for monitoring, and notify your doctor or nurse of any symptoms, such as rash, dizziness, hives, or trouble breathing.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place

Marketer details

Name: Biogen Idec Biotech India Pvt Ltd

Address: A-1/292, Ground Floor Janak Puri New Delhi West Delhi DL 110058 IN

Country of origin: India